Go back to the interactive dataset
2016 – Water risks that could impact companies’ direct operations
| Row number | Account Number | Company Name | Incorporated Country | CDP Program | Reporting Year | Access | Industry Activity Group | GiCS Sector | Country | River basin | Risk driver | Potential impact | Description of impact | Timeframe | Likelihood | Magnitude of potential financial impact | Response strategy | Costs of response strategy | Details of strategy and costs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2601 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Germany | Rhine | Reputational-Negative media coverage | Plant/production disruption leading to reduced output | Inability to maintain maximum production at this larger European site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Cost increase management through regulated tariff-setting process; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Increased capital expenditure; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Euros (fluctuated by foreign exchange rates with US Dollar). | Details of Euro cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (300,000); Lost market share (200,000); External engagement (5,000). |
| 2602 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Germany | Rhine | Physical-Declining water quality | Plant/production disruption leading to reduced output | Inability to maintain maximum production at this larger European site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Cost increase management through regulated tariff-setting process; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Increased capital expenditure; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Euros (fluctuated by foreign exchange rates with US Dollar). | Details of Euro cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (300,000); Lost market share (200,000); External engagement (5,000). |
| 2603 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Climate change | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2604 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Flooding | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2605 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Increased water scarcity | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2606 | 57963 | Birla Carbon | USA | Water | 2016 | Public | Chemicals | Materials | India | Other: Ganges, Cauvery and Patalganga | Physical-Flooding | Plant/production disruption leading to reduced output | Other potential impacts may include closure of operations, employee health and well-being, disruption to sales, property damage, supply chain disruption, and transport disruption. | Unknown | Probable | Unknown | Develop flood emergency plans; Engagement with suppliers; Establish site-specific targets; Infrastructure investment; Greater due diligence; Promote best practice and awareness; Supplier diversification | ||
| 2607 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Reputational-Changes in consumer behavior | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2608 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Other: Brand loyalty & market erosion. | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2609 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Inadequate infrastructure | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2610 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Increased water stress | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2611 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Projected water stress | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2612 | 57963 | Birla Carbon | USA | Water | 2016 | Public | Chemicals | Materials | Italy | Po | Physical-Flooding | Plant/production disruption leading to reduced output | Other potential impacts may include closure of operations, employee health and well-being, disruption to sales, property damage, supply chain disruption, and transport disruption. | Unknown | Probable | Unknown | Develop flood emergency plans; Engagement with suppliers; Infrastructure investment; Greater due diligence; Promote best practice and awareness; Supplier diversification | ||
| 2613 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Projected water scarcity | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2614 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Reputational-Inadequate access to water, sanitation and hygiene | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2615 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical- Pollution of water source | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2616 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Declining water quality | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2617 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Physical-Drought | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2618 | 57963 | Birla Carbon | USA | Water | 2016 | Public | Chemicals | Materials | Hungary | Danube | Physical-Drought | Plant/production disruption leading to reduced output | Other potential impacts may include closure of operations, employee health and well-being, disruption to sales, property damage, supply chain disruption, and transport disruption. | Unknown | Probable | Unknown | Develop flood emergency plans; Engagement with suppliers; Infrastructure investment; Greater due diligence; Supplier diversification | ||
| 2619 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin1513 | Reputational-Negative media coverage | Plant/production disruption leading to reduced output | In addition to hosting third-party manufacturing and research, this site is also a back-up for product manufacturing.Inability to maintain production & research at this larger American site could result from the identified water-risk drivers. Interrupted production would also result in decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Infrastructure investment; Infrastructure maintenance; Increased capital expenditure; Increased investment in new technology; Re-siting of facilities; Promote best practice and awareness | $900,000-950,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost third-party manufacturing contracts (300,000); Lost brand loyalty & market share (100,000); External engagement (5,000). |
| 2620 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Climate change | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2621 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Projected water scarcity | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2622 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Projected water stress | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2623 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Declining water quality | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2624 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Increased water scarcity | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2625 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Increased water stress | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2626 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical- Pollution of water source | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2627 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Dependency on hydropower | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2628 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Regulatory-Mandatory water efficiency, conservation, recycling or process standards | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2629 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Physical-Drought | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2630 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | United States of America | Other: GHAASBasin3920 | Reputational-Negative media coverage | Other: Disruption of R&D. | Inability to maintain research at this mid-sized American site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Medium-high | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Establish site-specific targets; Infrastructure investment; Infrastructure maintenance; Re-siting of facilities | $150,000-200,000 US dollars. | Details of dollar cost estimates & summary strategic activities: Re-siting/shift R&D (125,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2631 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Inadequate infrastructure | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2632 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Projected water scarcity | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2633 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Reputational-Inadequate access to water, sanitation and hygiene | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2634 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Drought | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2635 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Increased water scarcity | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2636 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Reputational-Negative media coverage | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2637 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Climate change | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2638 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Projected water stress | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2639 | 57963 | Birla Carbon | USA | Water | 2016 | Public | Chemicals | Materials | India | Other: Ganges, Cauvery and Patalganga | Physical-Seasonal supply variability/Inter annual variability | Plant/production disruption leading to reduced output | Other potential impacts may include closure of operations, employee health and well-being, disruption to sales, property damage, supply chain disruption, and transport disruption. | Unknown | Probable | Unknown | Develop flood emergency plans; Engagement with suppliers; Establish site-specific targets; Infrastructure investment; Greater due diligence; Promote best practice and awareness; Supplier diversification | ||
| 2640 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: AHAASBasin1591 | Physical-Increased water stress | Water supply disruption | Inability to maintain research at this smaller-sized site could result from the identified water-risk drivers. Interrupted research could result in negative media coverage and a need to shift R&D to another location via re-siting. | >6 years | Unlikely | Low-medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology | 100,000-150,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Re-siting/shift R&D to nearby site (75,000); Infrastructure investment & maintenance (50,000); External engagement (5,000). |
| 2641 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Drought | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2642 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Reputational-Inadequate access to water, sanitation and hygiene | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2643 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Projected water scarcity | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2644 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Reputational-Negative media coverage | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2645 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Inadequate infrastructure | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2646 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Projected water stress | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2647 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Other: Brand loyalty & market erosion. | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2648 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Climate change | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2649 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Increased water scarcity | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
| 2650 | 45103 | AbbVie Inc | USA | Water | 2016 | Public | Pharmaceuticals, Biotechnology & Life Sciences | Health Care | Singapore | Other: GHAASBasin1591 | Physical-Increased water stress | Water supply disruption | Inability to maintain maximum production at this larger Asian manufacturing site could result from the identified water-risk drivers. Water supply disruption would yield interrupted production and subsequent decreased sales and negative media coverage. Brand loyalty could erode with resulting decreased market share of impacted products in this key Asian market. | >6 years | Unlikely | Medium | Alignment of public policy positions with water stewardship goals; Engagement with community; Engagement with public policy makers; Engagement with other stakeholders in the river basin; Engagement with suppliers; Infrastructure investment; Infrastructure maintenance; Increased investment in new technology; Other: Shift manufacturing to backup site. | 500,000-550,000 Singapore dollars (fluctuated by foreign exchange rates with US Dollar). | Details of Singapore dollar cost estimates & summary strategic activities: Shift manufacturing, Capital expenditure & infrastructure investment (500,000); Lost market share (0 currently but will consider future impact); External engagement (3,000). |
About
This information is now on Primer
All the information that is in this pane, and more, is now on Primer, in a more consumable and user friendly format. You can also edit metadata from this page.
Take me there!
Description
CDP's water program motivates companies to disclose and reduce their environmental impacts by using the power of investors and customers. The data CDP collects help influential decision makers to reduce risk, capitalize on opportunities and drive action towards a more sustainable world. This dataset comes from question W3.2c asking companies to list the inherent water risks that could generate a substantive change in their business, operations, revenue or expenditure, the potential impact to their direct operations and the strategies to mitigate them.
Activity
- Community Rating
-
Current value: 0 out of 5
- Raters
- 0
- Visits
- 375
- Downloads
- 112
- Comments
- 0
- Contributors
- 0
Meta
- Category
- Companies
- Permissions
- Public
- Tags
- water, 2016
- Row Label
- SODA2 Only
- Yes
Licensing and Attribution
- Data Provided By
- (none)
- Source Link
- (none)
License Type
- License Type
- CDP Open Database License
